Pharmacogenetics in perspective

Drug Metabolism and Disposition

Volumn 29, Issue 4 II, 2001, Pages 468-470

  Kalow, W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENOTANE; INSECTICIDE; MIDAZOLAM; PHENYLBUTAZONE;

ANTIBIOTIC RESISTANCE; BIOEQUIVALENCE; CONFERENCE PAPER; DRUG CLEARANCE; DRUG RESPONSE; GENETIC VARIABILITY; HEREDITY; HUMAN; INFECTION RESISTANCE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL;

DRUG ADMINISTRATION SCHEDULE; EVOLUTION; HUMANS; PHARMACOGENETICS;

EID: 0035062375     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine
2. The genetics of epigenetics
3. Disease and Evolution
4. Pharmacoanthropology and the genetics of drug metabolism
5. Interethnic factors affecting drug respoase
6. Repeat administration of drugs as a means to assess the genetic component in pharmacological variability
7. The science of pharmacological variability: An essay
8. Caffeine as a metabolic probe: Exploration of the enzyme-inducing effect of cigarette smoking
9. Hypothesis: Comparison of inter- and intra-individual variations can substitute for twin studies in drug research
10. Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam
11. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
12. The role of DNA methylation in cancer genetic and epigenetics
13. On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation
14. Evaluation of the genetic component of variability in CYP3A4 activity: A repeated drug administration (RDA) method
15. Genetic variation of CNS receptors - A new perspective for pharmacogenetics
16. Dopamine and serotonin receptors: Amino acid sequences, and clinical role in neuroleptic Parkinsonism
17. Genomic imprinting of the X chromosome: A novel mechanism for the evolution of sexual dimorphism
18. Caffeine as a probe for CYP1A2 activity: Potential influence of renal factors on urinary phenotypic trait measurements
19. The error of determination of toxicity
20. Pharmacogenetic perspectives gained from twin and family studies